No Data
Kaisa Health Group Names New Auditor Amid Changes
Kaisa Health (00876) appointed Wingtak Wealth as the new auditor.
Kaisa Health (00876) announced that KPMG Certified Public Accountants (KPMG) after considering multiple factors...
Kaisa Health Restructures Board to Enhance Leadership
Kaisa Health (00876.HK): Liu Lihao, Luo Tingting, Xie Binhong, and Yu Huiming were appointed as executive directors.
On October 22, kaisa health (00876.HK) announced that Liu Lihao, Luo Tingting, Xie Binhong, and Yu Huiming have been appointed as executive directors of the company, effective from October 22, 2024.
KAISA HEALTH: INTERIM REPORT 2024
The performance of Kaisa Health (00876.HK) turned from a half-year profit to a loss of 24.264 million yuan.
Kaisa Health (00876.HK) announced its interim performance as of the end of June this year, with a revenue of 88.516 million yuan, a 4.4% year-on-year decrease. The profit turned into a loss of 24.264 million yuan, compared to a profit of 40.001 million yuan in the same period last year; resulting in a loss of 0.48 cents per share. No interim dividend will be distributed. The group stated that in the future, it will actively explore a medical instrument system based on the upstream and downstream of the oral industry chain, a veterinary services system combining medical care and health care, and the three systems will work together to form an ecological cycle.
No Data
No Data